1. Home
  2. HIPO vs YDES Comparison

HIPO vs YDES Comparison

Compare HIPO & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

HOLD

Current Price

$26.25

Market Cap

676.8M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.10

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HIPO
YDES
Founded
2015
2013
Country
United States
Taiwan
Employees
540
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
676.8M
543.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HIPO
YDES
Price
$26.25
$5.10
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$38.67
N/A
AVG Volume (30 Days)
71.6K
21.7K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.28
N/A
Revenue Next Year
$22.33
N/A
P/E Ratio
$7.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.92
$5.00
52 Week High
$38.98
$25.00

Technical Indicators

Market Signals
Indicator
HIPO
YDES
Relative Strength Index (RSI) 40.54 34.25
Support Level $24.85 N/A
Resistance Level $27.12 $13.19
Average True Range (ATR) 0.93 0.47
MACD -0.05 0.04
Stochastic Oscillator 40.48 7.19

Price Performance

Historical Comparison
HIPO
YDES

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: